Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIONID: Pentoxifylline and Nutritional Supplements in Hemodialysis Patients
NCT00561093Phase 3Completed
- Sponsor
- The Lundquist Institute
- Start
- Feb 2008
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pentoxifylline in malnutrition-inflammation-cachexia syndrome (MICS), sponsored by The Lundquist Institute. Started Feb 2008; status: completed.
02
Drugs
pentoxifylline
03
Conditions
malnutrition-inflammation-cachexia syndrome (MICS)
Beyond the preview
Go deeper on NCT00561093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00561093.